Anticancer Mechanisms

Boswellia is best understood in oncology through AKBA, the boswellic acid most strongly linked to anticancer activity. Its mechanism profile is broad and unusually relevant to inflammation-heavy and radioresistant tumour biology.

Primary mechanisms

1. Cell-cycle arrest

• Often induces G1/G0 arrest

• Downregulates cyclins and CDKs

• Upregulates p21 and p27 in several models

2. NF-κB and COX-2 inhibition

• Directly suppresses inflammatory tumour-survival signalling

• Reduces COX-2 expression in inflammation-driven cancers

• Lowers tumour-promoting cytokine activity

3. PI3K/Akt pathway inhibition

• Reduces phosphorylation of PI3K, Akt, and downstream targets

• Promotes apoptosis as a downstream consequence

• Relevant in resistant prostate and NSCLC models

4. EGFR-related pathway inhibition

• Reduces EGFR phosphorylation in breast cancer models

• Suppresses downstream migration and invasion signalling

• Decreases MMP-2 and MMP-9 while supporting invasion-suppressive proteins

5. Apoptosis induction

• Upregulates pro-apoptotic pathways

• Suppresses anti-apoptotic signalling

• Induces early and late apoptosis across multiple tumour types

6. Autophagy suppression

• Downregulates Beclin-1 and LC3 in relevant models

• Removes one route by which tumour cells evade death under stress

7. Anti-metastatic effects

• Downregulates CXCR4

• Inhibits EMT-linked signalling

• Suppresses MMPs and invasion-related biology

8. Anti-angiogenic effects

• Reduces VEGF expression

• Limits tumour neovascularisation in vivo

Secondary mechanisms

• epigenetic modulation

• miRNA regulation

• radioresistance reversal

• chemoresistance reversal

• 5-lipoxygenase inhibition

Practical interpretation

Boswellia / AKBA is especially interesting when inflammation, treatment resistance, oedema, or aggressive migration biology are central to the clinical picture.

Key References

Acetyl-keto-β-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells
https://pmc.ncbi.nlm.nih.gov/articles/PMC1752013/

AKBA exerts anti-cancer effects via cell cycle arrest, apoptosis induction and autophagy suppression in NSCLC
https://pmc.ncbi.nlm.nih.gov/articles/PMC6986255/

3-Acetyl-11-keto-β-boswellic acid inhibits cancer cell invasion and induces apoptosis in breast cancer by abrogating EGFR-mediated PI3K/Akt pathway
https://www.archivesofmedicalscience.com/pdf-119972-59621

Anti-cancer properties of boswellic acids: mechanism of action as an anti-cancerous agent
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1187181/full

AKBA suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and STAT3 signaling
https://pmc.ncbi.nlm.nih.gov/articles/PMC6786291/

Jump to another Boswellia page

Core pages

• Boswellia in Oncology Overview

• Evidence Summary

• Anticancer Mechanisms

• Boswellia Evidence by Cancer Type

Mechanism deep dives

• Redox Dual Action

• NRF2 Impact

• Ferroptosis Findings

• Immune Effects

Practical pages

• Pharmacokinetics & Metabolism

• Safety & Interactions

• Synergistic Combinations

• Hydroxychloroquine + Boswellia

• Dosing & Timing

• Sourcing Quality Boswellia

Cancer-type pages

• Glioblastoma & Brain Tumours

• Breast Cancer

• Colorectal Cancer

• Pancreatic Cancer

• Prostate Cancer

• Non-Small Cell Lung Cancer

• Ovarian Cancer

• Other Cancer Types